Ethotoin

Ethotoin
Ethotoin_synthesis.png
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Ethotoin is an anticonvulsant medication used primarily in the treatment of epilepsy. It is a member of the hydantoin class of drugs, which are known for their ability to stabilize neuronal membranes and reduce seizure activity.

Pharmacology

Ethotoin works by modulating the activity of sodium channels in the brain, which helps to prevent the excessive electrical activity that leads to seizures. Unlike some other anticonvulsants, Ethotoin is less likely to cause gingival hyperplasia or hirsutism.

Medical uses

Ethotoin is indicated for the management of tonic-clonic seizures and complex partial seizures. It is often used when other anticonvulsants, such as phenytoin, are not well tolerated by the patient.

Side effects

Common side effects of Ethotoin include drowsiness, dizziness, and ataxia. In some cases, patients may experience nausea, vomiting, or skin rash. Long-term use can lead to osteoporosis and folate deficiency.

Synthesis

Synthesis of Ethotoin

The synthesis of Ethotoin involves the reaction of ethyl acetoacetate with urea in the presence of a base to form the hydantoin ring. This process is a classic example of the Bucherer–Bergs reaction, which is commonly used in the synthesis of hydantoin derivatives.

History

Ethotoin was first introduced in the 1950s as an alternative to other anticonvulsants. It was developed to provide a treatment option with fewer side effects compared to phenobarbital and phenytoin.

Related pages

• Epilepsy
• Anticonvulsant
• Hydantoin
• Phenytoin